Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| January 31, 2024 | 90.72% |
| December 31, 2023 | 90.72% |
| November 30, 2023 | 90.72% |
| October 31, 2023 | 90.72% |
| September 30, 2023 | 90.72% |
| August 31, 2023 | 90.72% |
| July 31, 2023 | 90.72% |
| June 30, 2023 | 90.72% |
| May 31, 2023 | 90.72% |
| April 30, 2023 | 90.72% |
| March 31, 2023 | 90.72% |
| February 28, 2023 | 90.72% |
| January 31, 2023 | 90.72% |
| December 31, 2022 | 90.72% |
| November 30, 2022 | 90.72% |
| October 31, 2022 | 90.72% |
| September 30, 2022 | 90.72% |
| August 31, 2022 | 90.72% |
| July 31, 2022 | 90.72% |
| June 30, 2022 | 90.72% |
| May 31, 2022 | 90.72% |
| April 30, 2022 | 90.72% |
| March 31, 2022 | 90.72% |
| February 28, 2022 | 90.72% |
| January 31, 2022 | 90.72% |
| Date | Value |
|---|---|
| December 31, 2021 | 90.72% |
| November 30, 2021 | 90.72% |
| October 31, 2021 | 90.72% |
| September 30, 2021 | 92.07% |
| August 31, 2021 | 92.07% |
| July 31, 2021 | 92.07% |
| June 30, 2021 | 92.07% |
| May 31, 2021 | 92.07% |
| April 30, 2021 | 92.07% |
| March 31, 2021 | 92.07% |
| February 28, 2021 | 92.07% |
| January 31, 2021 | 92.07% |
| December 31, 2020 | 92.07% |
| November 30, 2020 | 92.07% |
| October 31, 2020 | 92.07% |
| September 30, 2020 | 92.07% |
| August 31, 2020 | 92.07% |
| July 31, 2020 | 92.07% |
| June 30, 2020 | 92.07% |
| May 31, 2020 | 92.07% |
| April 30, 2020 | 92.07% |
| March 31, 2020 | 92.07% |
| February 29, 2020 | 92.07% |
| January 31, 2020 | 92.07% |
| December 31, 2019 | 92.07% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
90.72%
Minimum
Oct 2021
92.07%
Maximum
May 2019
91.40%
Average
92.07%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| AbbVie Inc | 45.08% |
| Pfizer Inc | 54.78% |
| Johnson & Johnson | 27.36% |
| Merck & Co Inc | 27.26% |
| Cerevel Therapeutics Holdings Inc | -- |